IDEAYA Biosciences, Inc. (IDYA) earnings
IDYA earnings moved a median of -0.53% by the close. Quarterly and annual IDYA reports and results, each read against the price at its own news timestamp. Back to the IDYA overview →
22 measured IDYA earnings events.
Where these IDYA earnings landedvs 22 measured IDYA earnings reactions
| Middle 50% of IDYA earnings reactions | -0.99% to +1.10% |
|---|---|
| Median reaction (to close) | -0.53% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 IDYA earnings events with a measured close landed between -0.99% and +1.10%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q IDEAYA Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.08% | +1.22% | |
| IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business Update | Press release | +0.06% | -0.79% | |
| Form 10-Q IDEAYA Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.92% | -0.63% | |
| IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -1.41% | +0.06% | |
| Form 10-Q IDEAYA Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.96% | +1.77% | |
| IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | +1.39% | +2.42% | |
| Form 10-K IDEAYA Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.79% | +1.21% | |
| Form 10-Q IDEAYA Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.24% | -3.13% | |
| IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +0.41% | -0.97% | |
| Form 10-Q IDEAYA Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.12% | -1.67% | |
| IDEAYA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -1.16% | -3.75% | |
| Form 10-Q IDEAYA Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -5.70% | -2.35% | |
| IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +0.86% | -12.47% | |
| Form 10-K IDEAYA Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.25% | +1.82% | |
| Form 10-Q IDEAYA Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.71% | +0.75% | |
| IDEAYA Biosciences, Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | -0.95% | +4.06% | |
| Form 10-Q IDEAYA Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.17% | -0.99% | |
| Form 10-Q/A IDEAYA Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.17% | -0.99% | |
| IDEAYA Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +2.81% | -0.30% | |
| Form 10-Q IDEAYA Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.96% | |
| IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +1.02% | +0.71% | |
| Form 10-K IDEAYA Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.16% | -0.43% |
Keep exploring
More IDYA: analyst actions → · SEC filings → · IDYA overview →